首页> 外国专利> Combination drug suitable for treatment and prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration

Combination drug suitable for treatment and prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration

机译:适用于治疗和预防非酒精性脂肪肝疾病(NAFLD)和/或非酒精性脂肪性肝炎(NASH)和/或肝脂肪变性的联合药物

摘要

Problem to be Solved;To provide medicine and health food suitable for treatment and prevention for non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH) which are not involved with hepatic virus, and/or hepatic fatty degeneration.;Means for solving the problem;A combination drug suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration, wherein the active ingredients are zinc preparation and selenium preparation.
机译:有待解决的问题;提供适合治疗和预防与肝病毒和/或肝脂肪变性无关的非酒精性脂肪肝疾病(NAFLAD)和/或非酒精性脂肪性肝炎(NASH)的药物和保健食品解决问题的手段适用于治疗非酒精性脂肪性肝病(NAFLAD)和/或非酒精性脂肪性肝炎(NASH)和/或肝性脂肪变性的组合药物,其中有效成分为锌制剂和硒的制备。

著录项

  • 公开/公告号US2019336523A1

    专利类型

  • 公开/公告日2019-11-07

    原文格式PDF

  • 申请/专利权人 MEDICO CONSL CO. LTD;

    申请/专利号US201716473888

  • 发明设计人 SATORU KUBOTA;TORU KONO;

    申请日2017-11-30

  • 分类号A61K33/04;A61K31/355;A61K9;A61P1/16;

  • 国家 US

  • 入库时间 2022-08-21 12:08:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号